ArticleSSM - population health2026
Digital exclusion, functional limitations transitions, and life expectancy: a multinational longitudinal study.
Article in SSM - population health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study examined associations between digital exclusion and functional limitations transitions, and quantified impacts on life expectancy across diverse international contexts. Methods: We analyzed 124,332 adults aged ≥50 years across 23 countries using five harmonized longitudinal aging cohorts. Functional limitations were classified into functional independence, mild and severe functional limitations, with death as an absorbing state. Continuous-time multi-state Markov models examined associations between digital exclusion and transition patterns, while life expectancy was calculated through numerical integration of model parameters. Results: Digital exclusion demonstrated significant associations with adverse functional limitations transitions. Progression to mild limitations in three countries and Europe showed hazard ratios (HRs) of 1.47 (95% CI: 1.23-1.75) to 2.56 (95% CI: 1.38-4.75), and to severe limitations in four countries (excluding Europe) showed HRs of 1.24 (95% CI: 1.06-1.45) to 1.81 (95% CI: 1.15-2.86), while recovery from severe limitations was impaired in England, the United States and Europe (HR: 0.55 [95% CI: 0.48-0.62] to 0.74 [95% CI: 0.62-0.88]). Digital exclusion was associated with reductions in both functional life expectancy (3.72 years in Mexico to 14.27 years in China at age 50) and total life expectancy, with reductions largest at younger ages yet persisting through age 90; conversely, functional limitations duration increased in some countries. Conclusions: Digital exclusion is associated with functional limitations and reduced life expectancy, with associations varying across national contexts and most pronounced among younger age groups. Findings underscore the need to integrate digital inclusion into healthy aging policies while maintaining non-digital healthcare pathways.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.